Abstract:Induced pluripotent stem cells (iPSC) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques, which may open up new possibilities for regenerative medicine to treat diseases in the future. Biotechnological, chemical, and physical modulation techniques are different reprogramming cell technologies to obtain iPSC and present their respective strengths in iPSC reprogramming‐based regenerative therapies, such as hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. Induced pluripotent stem cells (iPSCs) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques. With their unlimited proliferative capacity and multifaceted differentiation potential and circumventing the ethical problems encountered in the application of embryonic stem cells (ESC), iPSCs have a broad application in the fields of cell therapy, drug screening, and disease models and may open up new possibilities for regenerative medicine to treat diseases in the future. In this review, we begin with different reprogramming cell technologies to obtain iPSCs, including biotechnological, chemical, and physical modulation techniques, and present their respective strengths, and limitations, as well as the recent progress of research. Secondly, we review recent research advances in iPSC reprogramming‐based regenerative therapies. iPSCs are now widely used to study various clinical diseases of hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. This review focuses on the translational clinical research around iPSCs as well as their potential for growth in the medical field. Finally, we summarize the overall review and look at the potential future of iPSCs in the field of cell therapy as well as tissue regeneration engineering and possible problems. We believe that the advancing iPSC research will help drive long‐awaited breakthroughs in cellular therapy.

[Therapeutic Cloning and Somatic Cell Reprogramming: Every Road Leads to Rome].

Therapeutic Cloning: the Progresses, Opportunities and Challenges

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Human Therapeutic Cloning, Pitfalls And Lack Luster Because Of Rapid Developments In Induced Pluripotent Stem Cell Technology

Somatic Cell Reprogramming for Regenerative Medicine: Scnt Vs. Ips Cells

Two Effective Routes For Removing Lineage Restriction Roadblocks: From Somatic Cells To Hepatocytes

Progress in the Reprogramming of Somatic Cells

Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells

The Progress of Induced Pluripotent Stem Cells Research in China

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Somatic reprogramming:Review of progress

Nuclear Reprogramming by Nuclear Transplantation and Defined Transcription Factors

Advance in the Role of Epigenetic Reprogramming in Somatic Cell Nuclear Transfer-Mediated Embryonic Development

Induced pluripotent stem cells: status quo and future

[Nuclear Transfer and Therapeutic Cloning].

Research Progress on Cell Reprogramming Induced by Small Molecule Compounds

Research progress in reprogramming induced pluripotent stem cells

Reprogramming stem cells in regenerative medicine

Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells

A poor imitation of a natural process: a call to reconsider the iPSC engineering technique.

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms